Thank you for subscribing to our blog.
We’ll hit your inbox next week with our latest post.

Latest Insights and Updates Delivered to your Inbox!

Subscribe now for exciting weekly industry news!

Top 8 Clinical Trial Trends for 2024 and Beyond
The clinical trials ecosystem is undergoing a transformative shift in 2024, fueled by technological advancements, regulatory updates, and an increasing focus on patient-centricity. As medical research continues to evolve, it is crucial to stay informed about the latest trends in clinical trials shaping the field. In this blog, we delve into the top...
5 Must Have Features in an Oncology CRO
Navitas Life Sciences joins The World Health Organization in raising awareness about cervical cancer this January, Cervical Cancer Awareness Month. According to the WHO, 604,000 were affected with cervical cancer globally in 2020, and it is the fourth most common type of cancer. In the UK, around 3,200 new cervical cancer cases are identified every...
The Impact of Generative AI in Clinical Trials
Generative AI in clinical trials, a subset of Artificial Intelligence (AI), holds promise as clinical trials not only should be flexible and adaptable but also cost-effective, catering to the diverse needs of various stakeholder groups. The intricacies of clinical trials, inherently labor-intensive, complex, and heavily regulated, make this task pa...
Top Pharma Articles of 2023: Year in review
Clinical Research Organizations (CROs) play a significant role in clinical research and in transforming healthcare. Ranging from catering to specialized niche pharmaceutical companies to expansive global pharma companies, CROs serve as the driving force behind the journey of new drugs and medical devices from conception to FDA approval. CRO’...
Managing Efficient Clinical Trials with CROs: Guide to Finding Top Clinical Research Organizations in 2024
Clinical trials present a complex landscape that demands meticulous navigation through the intricacies of protocol development, regulatory compliance, and trial management—an inherently formidable task. It is in this intricate terrain that Contract Research Organizations (CROs) assume a pivotal role, emerging as indispensable partners for sp...
Navitas Life Sciences’ Clinical Data Services: Showcasing at CPHI India 2023
Navitas Life Sciences boasts extensive experience in Clinical Data Services, covering a spectrum of crucial aspects including Data Management, Biostatistics & Programming, Data Standardization, Medical Writing, and Submissions. We are dedicated to delivering high-quality clinical trial data management while adhering to rigorous regulatory stand...
World Diabetes Day 2023: Supporting Diabetes Research through State-of-the-Art Euglycemic Clamp Studies
As we join the World Health Organization in observing the World Diabetes Day on November 14th, 2023, the global community faces an escalating diabetes crisis, demanding revolutionary advancements in therapeutic solutions. In this spirit, Navitas Life Sciences offers strategic partnerships to pharmaceutical companies, both large and small, in their ...
Leading Expert Insights on Drug Development and Immunology
Dr Narendra Chirmule Director of Biological Sciences at Symphony Technology In this exciting blog, we have the privilege of hearing from a seasoned expert, Dr Narendra Chirmule, PhD who has dedicated decades to advancing our understanding of immunology and pushing the boundaries of drug development. Dr Chirmule is a Director of Biological Sciences ...
Placing Patient Safety First: Preventing side effects and interactions with Medication Analysis
In our latest blog, Dr Philipp Hofmann, Director - Pharmacovigilance & QPPV, explores the significance of medication analysis, particularly for older patients in Germany. Offering a professional assessment, this analysis addresses crucial questions regarding potential adverse drug reactions and interactions. Dr Hofmann provides a comprehensive ...
pvindia Autumn forum success: Unlocking Pharmacovigilance Insights for a Safer World
In the ever-evolving landscape of Pharmacovigilance (PV), a parallel momentum is gaining traction — the imperative for transparency and heightened responsibility towards ensuring patient safety. Organizations operating in PV are now facing heightened pressure to demonstrate tangible progress. Transparency is the need of the hour. As we stand...

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us